Loading...

Hogy MedicalLtd

OTCPK:HGYM.F
Snowflake Description

Excellent balance sheet with acceptable track record.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
HGYM.F
OTCPK
¥107B
Market Cap
  1. Home
  2. US
  3. Healthcare
Company description

Hogy Medical Co.,Ltd. develops and supplies various medical products for healthcare facilities in Japan and internationally. The last earnings update was 3 days ago. More info.


Add to Portfolio Compare Print
HGYM.F Share Price and Events
7 Day Returns
0%
OTCPK:HGYM.F
4.2%
US Medical Equipment
2.8%
US Market
1 Year Returns
-
OTCPK:HGYM.F
10.9%
US Medical Equipment
-5.6%
US Market
HGYM.F Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Hogy MedicalLtd (HGYM.F) 0% 0% - - - -
US Medical Equipment 4.2% 6.9% 0.1% 10.9% 63.4% 85.1%
US Market 2.8% 7.7% -3.1% -5.6% 40.1% 41.1%
1 Year Return vs Industry and Market
  • No trading data on HGYM.F.
  • No trading data on HGYM.F.
Price Volatility
Industry
5yr Volatility vs Market
Related Companies

Sorry, no analysis for Hogy MedicalLtd's competitors could be found in our database.

Value

 Is Hogy MedicalLtd undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Hogy MedicalLtd to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Hogy MedicalLtd.

OTCPK:HGYM.F Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 4 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 9.3%
Perpetual Growth Rate 10-Year US Government Bond Rate 2.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for OTCPK:HGYM.F
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 2.7%
Equity Risk Premium S&P Global 7.3%
Medical Equipment Unlevered Beta Simply Wall St/ S&P Global 0.91
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.908 (1 + (1- 30.86%) (0.32%))
0.91
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.91
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (0.91 * 7.27%)
9.35%

Discounted Cash Flow Calculation for OTCPK:HGYM.F using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Hogy MedicalLtd is arrived at by discounting future cash flows to their present value using the 2 stage method. We use analyst's estimates of cash flows going forward 5 years for the 1st stage, the 2nd stage assumes the company grows at a stable rate into perpetuity.

OTCPK:HGYM.F DCF 1st Stage: Next 5 year cash flow forecast
2019 2020 2021 2022 2023
Levered FCF (JPY, Millions) 8,610.00 5,255.00 5,500.00 4,300.00 5,000.00
Source Analyst x2 Analyst x2 Analyst x2 Analyst x1 Analyst x1
Present Value
Discounted (@ 9.35%)
7,874.01 4,395.00 4,206.70 3,007.74 3,198.42
Present value of next 5 years cash flows ¥22,681.87
OTCPK:HGYM.F DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2023 × (1 + g) ÷ (Discount Rate – g)
= ¥5,000.00 × (1 + 2.73%) ÷ (9.35% – 2.73%)
¥77,625.41
Present Value of Terminal Value = Terminal Value ÷ (1 + r)5
= ¥77,625.41 ÷ (1 + 9.35%)5
¥49,655.67
OTCPK:HGYM.F Total Equity Value
Calculation Result
Total Equity Value = Present value of next 5 years cash flows + Terminal Value
= ¥22,681.87 + ¥49,655.67
¥72,337.54
Equity Value per Share
(JPY)
= Total value / Shares Outstanding
= ¥72,337.54 / 30.19
¥19.58
OTCPK:HGYM.F Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in OTCPK:HGYM.F represents 0.00817x of TSE:3593
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.00817x
Value per Share
(Listing Adjusted, USD)
= Value per Share (JPY) x Listing Adjustment Factor
= ¥ 2,396.47 x 0.00817
$19.58
Value per share (USD) From above. $19.58
Current discount Discount to share price of $29.05
= -1 x ($29.05 - $19.58) / $19.58
-48.3%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Hogy MedicalLtd is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Hogy MedicalLtd's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Hogy MedicalLtd's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
OTCPK:HGYM.F PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in JPY ¥204.71
TSE:3593 Share Price ** TSE (2018-10-22) in JPY ¥3555
United States of America Medical Equipment Industry PE Ratio Median Figure of 63 Publicly-Listed Medical Equipment Companies 47.81x
United States of America Market PE Ratio Median Figure of 3,023 Publicly-Listed Companies 17.12x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Hogy MedicalLtd.

OTCPK:HGYM.F PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= TSE:3593 Share Price ÷ EPS (both in JPY)

= 3555 ÷ 204.71

17.37x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Hogy MedicalLtd is good value based on earnings compared to the US Medical Equipment industry average.
  • Hogy MedicalLtd is overvalued based on earnings compared to the United States of America market.
Price based on expected Growth
Does Hogy MedicalLtd's expected growth come at a high price?
Raw Data
OTCPK:HGYM.F PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 17.37x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 4 Analysts
1.9%per year
United States of America Medical Equipment Industry PEG Ratio Median Figure of 53 Publicly-Listed Medical Equipment Companies 2.74x
United States of America Market PEG Ratio Median Figure of 2,108 Publicly-Listed Companies 1.28x

*Line of best fit is calculated by linear regression .

OTCPK:HGYM.F PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 17.37x ÷ 1.9%

9.34x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Hogy MedicalLtd is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on Hogy MedicalLtd's assets?
Raw Data
OTCPK:HGYM.F PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in JPY ¥3,007.18
TSE:3593 Share Price * TSE (2018-10-22) in JPY ¥3555
United States of America Medical Equipment Industry PB Ratio Median Figure of 181 Publicly-Listed Medical Equipment Companies 4.09x
United States of America Market PB Ratio Median Figure of 5,099 Publicly-Listed Companies 1.78x
OTCPK:HGYM.F PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= TSE:3593 Share Price ÷ Book Value per Share (both in JPY)

= 3555 ÷ 3,007.18

1.18x

* Primary Listing of Hogy MedicalLtd.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Hogy MedicalLtd is good value based on assets compared to the US Medical Equipment industry average.
X
Value checks
We assess Hogy MedicalLtd's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check)
  5. Hogy MedicalLtd has a total score of 2/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Hogy MedicalLtd expected to perform in the next 1 to 3 years based on estimates from 4 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
1.9%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Hogy MedicalLtd expected to grow at an attractive rate?
  • Hogy MedicalLtd's earnings growth is positive but not above the low risk savings rate of 2.7%.
Growth vs Market Checks
  • Hogy MedicalLtd's earnings growth is positive but not above the United States of America market average.
  • Hogy MedicalLtd's revenue growth is positive but not above the United States of America market average.
Annual Growth Rates Comparison
Raw Data
OTCPK:HGYM.F Future Growth Rates Data Sources
Data Point Source Value (per year)
OTCPK:HGYM.F Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 4 Analysts 1.9%
OTCPK:HGYM.F Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 4 Analysts 7.1%
United States of America Medical Equipment Industry Earnings Growth Rate Market Cap Weighted Average 28.7%
United States of America Medical Equipment Industry Revenue Growth Rate Market Cap Weighted Average 7.6%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.7%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
OTCPK:HGYM.F Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 weeks ago) See Below
Future Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below
All numbers in JPY Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
OTCPK:HGYM.F Future Estimates Data
Date (Data in JPY Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-03-31 50,800 7,000 6,750 1
2022-03-31 47,000 6,300 5,750 1
2021-03-31 40,545 7,901 4,646 4
2020-03-31 38,579 7,984 4,043 4
2019-03-31 37,138 10,473 5,374 4
OTCPK:HGYM.F Past Financials Data
Date (Data in JPY Millions) Revenue Cash Flow Net Income *
2018-12-31 36,755 7,731 6,296
2018-09-30 36,729 8,033 6,210
2018-06-30 36,812 7,638 3,554
2018-03-31 36,918 8,367 5,262
2017-12-31 37,193 8,438 5,628
2017-09-30 36,976 7,455 6,687
2017-06-30 36,963 8,174 6,964
2017-03-31 36,859 10,066 5,786
2016-12-31 37,305 10,897 6,106
2016-09-30 37,226 10,988 5,560
2016-06-30 36,984 9,341 5,847
2016-03-31 36,568 6,809 5,910

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Hogy MedicalLtd's earnings are expected to grow by 1.9% yearly, however this is not considered high growth (20% yearly).
  • Hogy MedicalLtd's revenue is expected to grow by 7.1% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
OTCPK:HGYM.F Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 weeks ago) See Below
Future Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below

All data from Hogy MedicalLtd Company Filings, last reported 2 weeks ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:HGYM.F Future Estimates Data
Date (Data in JPY Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-03-31 223.70 223.70 223.70 1.00
2022-03-31 190.56 190.56 190.56 1.00
2021-03-31 142.08 176.42 94.55 5.00
2020-03-31 123.78 157.10 82.92 5.00
2019-03-31 174.98 175.32 174.65 2.00
OTCPK:HGYM.F Past Financials Data
Date (Data in JPY Millions) EPS *
2018-12-31 204.71
2018-09-30 200.06
2018-06-30 113.67
2018-03-31 168.04
2017-12-31 179.76
2017-09-30 213.63
2017-06-30 222.37
2017-03-31 184.53
2016-12-31 194.49
2016-09-30 176.86
2016-06-30 185.87
2016-03-31 187.87

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Hogy MedicalLtd is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Hogy MedicalLtd's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Hogy MedicalLtd has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Hogy MedicalLtd performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Hogy MedicalLtd's growth in the last year to its industry (Medical Equipment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Hogy MedicalLtd's year on year earnings growth rate has been positive over the past 5 years.
  • Hogy MedicalLtd's 1-year earnings growth exceeds its 5-year average (11.9% vs 0.3%)
  • Hogy MedicalLtd's earnings growth has exceeded the US Medical Equipment industry average in the past year (11.9% vs 11.7%).
Earnings and Revenue History
Hogy MedicalLtd's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Hogy MedicalLtd Company Filings, last reported 2 weeks ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:HGYM.F Past Revenue, Cash Flow and Net Income Data
Date (Data in JPY Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 36,755.00 6,296.00 9,165.00
2018-09-30 36,729.00 6,210.00 8,912.00
2018-06-30 36,812.00 3,554.00 8,565.00
2018-03-31 36,918.00 5,262.00 8,322.00
2017-12-31 37,193.00 5,628.00 8,224.00
2017-09-30 36,976.00 6,687.00 8,143.00
2017-06-30 36,963.00 6,964.00 8,129.00
2017-03-31 36,859.00 5,786.00 8,053.00
2016-12-31 37,305.00 6,106.00 7,837.00
2016-09-30 37,226.00 5,560.00 7,853.00
2016-06-30 36,984.00 5,847.00 7,791.00
2016-03-31 36,568.00 5,910.00 7,755.00
2015-12-31 35,756.00 5,770.00 7,805.00
2015-09-30 35,648.00 5,902.00 7,750.00
2015-06-30 35,474.00 5,833.00 7,841.00
2015-03-31 35,233.00 5,659.00 7,921.00
2014-12-31 34,917.00 5,495.00 8,084.00
2014-09-30 34,973.00 5,622.00 8,184.00
2014-06-30 34,820.00 5,574.00 8,138.00
2014-03-31 34,793.00 5,632.00 8,077.00
2013-12-31 34,299.00 5,697.00 7,557.00 481.00
2013-09-30 33,835.00 5,530.00 7,406.00 481.00
2013-06-30 33,425.00 5,358.00 7,341.00 481.00
2013-03-31 33,094.00 5,247.00 7,274.00 481.00
2012-12-31 32,998.00 5,129.00 7,544.00 344.00
2012-09-30 32,354.00 4,774.00 7,473.00 344.00
2012-06-30 32,075.00 4,568.00 7,420.00 344.00
2012-03-31 31,873.00 4,624.00 7,344.00 344.00

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Hogy MedicalLtd has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Hogy MedicalLtd used its assets less efficiently than the US Medical Equipment industry average last year based on Return on Assets.
  • Hogy MedicalLtd's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Hogy MedicalLtd's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Hogy MedicalLtd has a total score of 3/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Hogy MedicalLtd's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Hogy MedicalLtd's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Hogy MedicalLtd is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Hogy MedicalLtd's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Hogy MedicalLtd's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 126.7x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Hogy MedicalLtd Company Filings, last reported 2 weeks ago.

OTCPK:HGYM.F Past Debt and Equity Data
Date (Data in JPY Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 90,779.00 341.00 21,736.00
2018-09-30 90,828.00 341.00 21,137.00
2018-06-30 92,394.00 399.00 18,284.00
2018-03-31 94,062.00 845.00 21,274.00
2017-12-31 93,463.00 453.00 19,194.00
2017-09-30 91,352.00 453.00 19,911.00
2017-06-30 90,488.00 508.00 19,304.00
2017-03-31 89,628.00 1,383.00 16,658.00
2016-12-31 88,815.00 566.00 12,633.00
2016-09-30 86,711.00 566.00 11,974.00
2016-06-30 87,377.00 0.00 13,641.00
2016-03-31 87,608.00 1,291.00 12,380.00
2015-12-31 87,559.00 0.00 10,504.00
2015-09-30 85,250.00 0.00 11,062.00
2015-06-30 84,353.00 0.00 15,198.00
2015-03-31 83,301.00 6,237.00 23,033.00
2014-12-31 80,287.00 0.00 21,924.00
2014-09-30 77,784.00 0.00 24,424.00
2014-06-30 76,075.00 0.00 28,025.00
2014-03-31 75,379.00 303.00 28,595.00
2013-12-31 74,455.00 0.00 25,078.00
2013-09-30 72,547.00 0.00 24,712.00
2013-06-30 71,057.00 0.00 22,933.00
2013-03-31 69,601.00 231.00 22,471.00
2012-12-31 67,529.00 0.00 20,076.00
2012-09-30 65,891.00 0.00 19,902.00
2012-06-30 65,132.00 0.00 19,537.00
2012-03-31 64,013.00 479.00 19,610.00
  • Hogy MedicalLtd's level of debt (0.4%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (0% vs 0.4% today).
  • Debt is well covered by operating cash flow (2267.2%, greater than 20% of total debt).
  • Hogy MedicalLtd earns more interest than it pays, coverage of interest payments is not a concern.
X
Financial health checks
We assess Hogy MedicalLtd's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Hogy MedicalLtd has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Hogy MedicalLtd's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
1.8%
Current annual income from Hogy MedicalLtd dividends. Estimated to be 1.86% next year.
If you bought $2,000 of Hogy MedicalLtd shares you are expected to receive $36 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Hogy MedicalLtd's pays a higher dividend yield than the bottom 25% of dividend payers in United States of America (1.45%).
  • Hogy MedicalLtd's dividend is below the markets top 25% of dividend payers in United States of America (3.7%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
OTCPK:HGYM.F Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below
United States of America Medical Equipment Industry Average Dividend Yield Market Cap Weighted Average of 23 Stocks 1.3%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 1986 Stocks 2.6%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.9%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.5%
United States of America Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

OTCPK:HGYM.F Future Dividends Estimate Data
Date (Data in ¥) Dividend per Share (annual) Avg. No. Analysts
2023-03-31 82.00 1.00
2022-03-31 72.00 1.00
2021-03-31 65.27 5.00
2020-03-31 64.67 5.00
2019-03-31 64.07 5.00
OTCPK:HGYM.F Past Annualized Dividends Data
Date (Data in ¥) Dividend per share (annual) Avg. Yield (%)
2019-01-16 64.000 1.857
2018-11-07 64.000 1.982
2018-08-08 64.000 1.745
2018-07-11 64.000 1.623
2018-06-22 64.000 1.337
2018-04-11 64.000 1.350
2018-02-07 62.000 1.478
2018-01-16 62.000 1.483
2017-11-08 62.000 1.495
2017-10-12 62.000 1.599
2017-08-14 62.000 1.552
2017-07-12 62.000 1.544
2017-06-23 62.000 1.649
2017-04-12 62.000 1.678
2017-02-08 60.000 1.759
2017-01-16 60.000 1.755
2016-11-09 60.000 1.749
2016-10-13 60.000 1.760
2016-08-10 60.000 1.725
2016-07-12 60.000 1.740
2016-06-24 60.000 1.674
2016-04-12 60.000 1.868
2016-02-10 58.000 2.009
2016-01-14 58.000 2.023
2015-11-11 58.000 1.881
2015-10-13 58.000 2.007
2015-08-12 58.000 2.018
2015-07-10 58.000 1.904
2015-06-19 58.000 1.816
2015-04-10 58.000 1.909
2015-02-12 56.000 1.858
2015-01-15 56.000 1.904
2014-11-12 56.000 1.984
2014-10-10 56.000 2.002
2014-08-13 56.000 1.914
2014-07-10 56.000 1.963
2014-06-20 56.000 2.046
2014-04-10 56.000 2.084
2013-10-10 54.000 2.002
2013-08-07 54.000 1.976
2013-07-10 54.000 1.851
2013-04-10 54.000 1.884
2013-01-17 50.000 2.118
2012-08-08 48.000 2.388
2012-07-11 48.000 2.576
2012-06-22 48.000 2.721
2012-04-11 48.000 2.829
2012-01-16 43.000 2.519
2011-11-09 40.000 2.508
2011-10-13 40.000 2.402
2011-08-10 40.000 2.348
2011-07-12 40.000 2.301
2011-06-23 40.000 2.235
2011-04-19 40.000 2.343
2011-02-09 50.000 2.791
2011-01-17 50.000 2.605
2010-11-10 50.000 2.593
2010-10-13 50.000 2.689
2010-08-11 50.000 2.423
2010-07-15 50.000 2.383
2010-07-12 50.000 2.351
2010-06-24 46.000 2.139
2010-04-12 46.000 1.997
2010-02-12 46.000 2.078
2010-01-04 46.000 2.042
2009-11-11 46.000 1.987
2009-10-16 46.000 1.920
2009-08-12 46.000 1.850
2009-07-14 46.000 1.872
2009-06-24 46.000 1.878
2009-04-13 46.000 1.817
2009-02-13 46.000 1.718
2009-01-20 46.000 1.726

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Dividends per share have increased over the past 10 years.
Current Payout to shareholders
What portion of Hogy MedicalLtd's earnings are paid to the shareholders as a dividend.
  • Dividends paid are well covered by earnings (3.2x coverage).
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Hogy MedicalLtd's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.9%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Hogy MedicalLtd afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Hogy MedicalLtd has a total score of 3/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Hogy MedicalLtd's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Jun-Ichi Hoki
AGE 58
CEO Bio

Mr. Jun-Ichi Hoki serves as the President and Chief Executive Officer of Hogy Medical Co., Ltd. Mr. Hoki served as Chief Operating Officer, Executive Vice President and a Senior Managing Director of Hogy Medical Co., Ltd. He serves as a Representative Director of Hogy Medical Co., Ltd.

CEO Compensation
  • Insufficient data for Jun-Ichi to compare compensation growth.
  • Insufficient data for Jun-Ichi to establish whether their remuneration is reasonable compared to companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the Hogy MedicalLtd management team in years:

1.3
Average Tenure
59
Average Age
  • The average tenure for the Hogy MedicalLtd management team is less than 2 years, this suggests a new team.
Management Team

Jun-Ichi Hoki

TITLE
CEO, President & Representative Director
AGE
58

Susumu Ohashi

TITLE
Executive Officer of System Administration Dept. & Administration Dept.

Yukio Yamamoto

TITLE
GM of Sales Division & Executive Director
AGE
64

Katsuo Sasaki

TITLE
Director of Production Division & Director
AGE
60

Takuya Kobayashi

TITLE
GM of Group 1
AGE
53
TENURE
1.6 yrs

Akira Koizumi

TITLE
Executive Officer of Production Division & Procurement Dept.

Wataru Fujimoto

TITLE
Executive Officer of Sales Dept.2 & Sales GM of Group 5
TENURE
1.6 yrs

Hisato Komatsu

TITLE
Executive Officer of Global Business Division
TENURE
0.8 yrs

Hideki Kawakubo

TITLE
Executive Officer of Management Planning Department
TENURE
1 yrs
Board of Directors Tenure

Average tenure and age of the Hogy MedicalLtd board of directors in years:

1.6
Average Tenure
64
Average Age
  • The average tenure for the Hogy MedicalLtd board of directors is less than 3 years, this suggests a new board.
Board of Directors

Jun-Ichi Hoki

TITLE
CEO, President & Representative Director
AGE
58

Yukio Yamamoto

TITLE
GM of Sales Division & Executive Director
AGE
64
TENURE
1.6 yrs

Katsuo Sasaki

TITLE
Director of Production Division & Director
AGE
60

Takuya Kobayashi

TITLE
GM of Group 1
AGE
53

Kiyoshi Uesugi

TITLE
Outside Director
AGE
68
TENURE
2.6 yrs

Ichiro Inoue

TITLE
Outside Board Member
TENURE
0.6 yrs

Ikuo Fuse

TITLE
Full-Time Corporate Auditor
TENURE
1.6 yrs

Shuji Yanase

TITLE
Outside Corporate Auditor
AGE
77

Noboru Iizuka

TITLE
Outside Corporate Auditor
AGE
66
TENURE
2.6 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess Hogy MedicalLtd's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Hogy MedicalLtd has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

External News
Loading...
Simply Wall St News

Company Info

Map
Description

Hogy Medical Co.,Ltd. develops and supplies various medical products for healthcare facilities in Japan and internationally. The company offers kit products for surgery applications; and non-woven products, including gowns, caps, underwear, drapes, packaged products, equipment covers, kurumu, towels, and accessories, as well as isolation gowns, caps, masks for use in operating rooms, outpatient areas, hospital wards, and other areas; and Tigalyer, a multi-layer fabric. It also provides sterilization products, such as hybrid Mekkin bags, hybrid Mekkin bags ID layered type, and autoclave forceps stand caps; Mekkin cards, which are detection cards used to judge the sterilization process when sterilizing in an autoclave; ethylene oxide gas cards that are detection cards used to judge the sterilization process when sterilizing using ethylene oxide gas; and indicator tapes for autoclave sterilization. In addition, the company offers IC Tracer, a gauze control system that uses integrated circuit chips embedded in each gauze used during surgery, making each one traceable; ASRC, a product made of a foamed polyethylene sponge that provides flexibility and functionality for use in varying procedures and inosculations; and Securea, a polyurethane sponge for endoscopic surgery. The company was formerly known as Hogy Co., Ltd. and changed its name to Hogy Medical Co.,Ltd. in 1987. Hogy Medical Co.,Ltd. was founded in 1955 and is headquartered in Tokyo, Japan.

Details
Name: Hogy Medical Co.,Ltd.
HGYM.F
Exchange: OTCPK
Founded: 1955
¥977,660,563
30,185,098
Website: http://www.hogy.co.jp
Address: Hogy Medical Co.,Ltd.
7-7, Akasaka 2-chome,
Minato-ku,
Tokyo,
107-8615,
Japan
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
TSE 3593 Common Stock The Tokyo Stock Exchange JP JPY 19. May 1992
OTCPK HGYM.F Common Stock Pink Sheets LLC US USD 19. May 1992
Number of employees
Current staff
Staff numbers
1,472
Hogy MedicalLtd employees.
Industry
Health Care Supplies
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/01/19 23:53
End of day share price update: 2018/10/22 00:00
Last estimates confirmation: 2019/01/16
Last earnings filing: 2019/01/16
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/03/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.